The insider sales are routine and small relative to market cap, with the CCO's sale tied to option exercise. No bearish signal. Monitor upcoming quarterly results for commercial progress of neffy (epinephrine nasal spray), which is the primary catalyst for SPRY.
Price Chart
Executive Summary
Two C-suite insiders at ARS Pharmaceuticals (SPRY) sold shares on June 12, 2026, totaling $284K in open-market sales. The Chief Commercial Officer exercised options and immediately sold the shares, while the Chief Legal Officer sold a smaller block. The total sales represent ~0.03% of market cap, a trivial amount that does not signal material bearish conviction.
Key Financial Metrics
Key Facts
- Chief Commercial Officer Karas Eric exercised 25,000 options at $0 and $1.50, then sold all 25,000 shares at $10 for $250K.
- Chief Legal Officer Fitzpatrick Alexander A sold 3,355 shares at $10 for $33,550.
- Total open-market sales: $283,550, or ~0.03% of SPRY's $952M market cap.
- No insider purchases were reported in the cluster window.
- The CCO's sale is a typical cashless exercise-and-sell pattern, not a conviction-driven disposition.
Financial Impact
Total insider sales of ~$284K, representing ~0.03% of market cap — immaterial.
Risk Factors
- Insider sales could increase if more options vest and are exercised.
- Commercial execution risk for neffy post-launch.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SPRY-1781309207138 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | 144 | $4.29 $4.18 | ▲ +2.56% | ▲ +3.09% | $4.03 (+6.06%) |
Sep 28, 2026 28d ago | Court Ruling | $4.40 $4.31 | ▼ −2.05% | ▼ −1.84% | $4.03 (−8.41%) |
Sep 16, 2026 5w ago | Court Ruling | $4.15 $4.11 | ▼ −0.96% | ▼ −0.84% | $4.03 (−2.89%) |
Aug 3, 2026 12w ago | Press Release | $5.46 $5.32 | ▼ −2.56% | ▼ −4.37% | $4.03 (−26.19%) |
Jul 17, 2026 14w ago | Court Ruling | $6.44 $6.36 | ▼ −1.24% | ▼ −2.08% | $4.03 (−37.42%) |
Jul 7, 2026 15w ago | 8-K | $8.10 $7.88 | ▼ −2.72% | ▼ −3.56% | $4.03 (−50.25%) |
Jun 12, 2026 19w ago | Insider Cluster | $9.81 $9.70 | ▼ −1.12% | ▼ −0.53% | $4.03 (−58.92%) |
May 15, 2026 23w ago | 8-K | $7.43 $7.30 | ▼ −1.68% | ▼ −1.62% | $4.03 (−45.72%) |
May 15, 2026 23w ago | Press Release | $7.43 $7.30 | ▲ +1.68% | ▲ +1.62% | $4.03 (+45.72%) |
May 13, 2026 23w ago | 8-K | $8.01 $7.94 | ▼ −0.87% | ▼ −1.65% | $4.03 (−49.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers